Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (405)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
144
4.150
Why?
Vulvar Neoplasms
6
2024
60
2.570
Why?
Carcinoma, Squamous Cell
9
2024
331
2.060
Why?
Carcinoma in Situ
7
2022
72
1.800
Why?
Uterine Neoplasms
10
2023
57
1.800
Why?
Carcinoma, Endometrioid
6
2021
38
1.490
Why?
Adenocarcinoma
10
2024
403
1.460
Why?
Tumor Suppressor Protein p53
3
2024
224
1.370
Why?
PAX2 Transcription Factor
7
2015
24
1.330
Why?
Ovarian Neoplasms
10
2024
455
1.100
Why?
Uterine Cervical Neoplasms
7
2024
299
1.090
Why?
Endometrial Hyperplasia
4
2019
14
1.050
Why?
Cannabidiol
6
2024
44
1.010
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2024
62
1.000
Why?
Stromal Cells
2
2016
76
0.950
Why?
Female
66
2024
28277
0.850
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.830
Why?
Plant Extracts
6
2024
199
0.800
Why?
Myometrium
2
2013
13
0.790
Why?
Endometrium
6
2023
43
0.760
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.720
Why?
Immunohistochemistry
16
2024
977
0.700
Why?
Precancerous Conditions
3
2019
87
0.690
Why?
Cannabis
6
2024
152
0.690
Why?
Aged, 80 and over
20
2024
3449
0.660
Why?
Middle Aged
35
2024
13133
0.640
Why?
Humans
70
2024
52441
0.640
Why?
Cystadenocarcinoma, Serous
4
2013
73
0.630
Why?
Peripheral Nerves
2
2015
47
0.580
Why?
Mutation
9
2024
1331
0.550
Why?
Aged
29
2024
10242
0.540
Why?
Placenta
6
2021
147
0.530
Why?
Cervix Uteri
2
2017
49
0.520
Why?
Epithelial-Mesenchymal Transition
2
2016
56
0.510
Why?
Adult
31
2024
14205
0.510
Why?
Adenosarcoma
1
2016
3
0.500
Why?
Polyps
1
2016
21
0.490
Why?
Uterine Cervical Dysplasia
1
2016
51
0.480
Why?
Lymphatic Metastasis
6
2019
210
0.470
Why?
Neoplasm Staging
9
2024
768
0.470
Why?
Papillomavirus Infections
3
2024
170
0.460
Why?
Fallopian Tubes
2
2012
22
0.460
Why?
Fibroma
1
2015
40
0.460
Why?
Tumor Microenvironment
4
2021
257
0.450
Why?
Prognosis
11
2024
2100
0.420
Why?
Neoplasm Invasiveness
6
2019
278
0.410
Why?
Observer Variation
4
2024
134
0.410
Why?
Pelvic Neoplasms
1
2011
13
0.360
Why?
Uterus
3
2023
87
0.360
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
86
0.350
Why?
Mice, Inbred C57BL
7
2024
1888
0.330
Why?
Ejaculatory Ducts
1
2010
3
0.330
Why?
Seminal Vesicles
1
2010
13
0.330
Why?
Neoplasm Recurrence, Local
4
2015
639
0.330
Why?
Spectrum Analysis, Raman
2
2021
42
0.320
Why?
Reproducibility of Results
5
2024
1223
0.320
Why?
Prostate
1
2010
116
0.310
Why?
Mice
16
2024
5899
0.310
Why?
Bromcresol Purple
1
2009
3
0.300
Why?
Electrophoresis, Capillary
1
2009
10
0.300
Why?
Serum Albumin
1
2009
57
0.300
Why?
Human papillomavirus 16
2
2021
44
0.290
Why?
Methionine
2
2020
142
0.280
Why?
beta Catenin
2
2021
105
0.280
Why?
Predictive Value of Tests
5
2024
938
0.280
Why?
Disease Progression
4
2020
870
0.280
Why?
Liver
4
2024
1150
0.280
Why?
Diabetes Mellitus
2
2023
318
0.270
Why?
Genital Neoplasms, Female
2
2018
48
0.270
Why?
Papillomavirus Vaccines
2
2021
69
0.270
Why?
Anus Neoplasms
2
2018
26
0.270
Why?
Cell Proliferation
4
2021
1013
0.260
Why?
Metaplasia
2
2019
16
0.260
Why?
Antigens, CD
2
2019
213
0.260
Why?
Diagnosis, Differential
8
2020
1028
0.260
Why?
Prostatic Neoplasms
1
2010
398
0.250
Why?
Melanoma
2
2020
272
0.250
Why?
Colitis
2
2020
49
0.250
Why?
Polyethylene Glycols
2
2017
93
0.240
Why?
Neoplasm Grading
5
2021
127
0.240
Why?
Gold
2
2017
81
0.240
Why?
Hypertension
2
2021
560
0.240
Why?
Animals
17
2024
13485
0.230
Why?
Chi-Square Distribution
2
2016
292
0.230
Why?
Proteomics
3
2017
332
0.230
Why?
Nanoparticles
2
2017
131
0.230
Why?
Aspartic Acid Endopeptidases
2
2015
17
0.220
Why?
Lab-On-A-Chip Devices
1
2024
10
0.220
Why?
Young Adult
7
2024
4346
0.220
Why?
Racemases and Epimerases
2
2015
18
0.220
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.220
Why?
Retrospective Studies
11
2020
6694
0.210
Why?
Carcinoma, Neuroendocrine
1
2024
27
0.210
Why?
Neuroendocrine Tumors
1
2024
25
0.210
Why?
DNA Mutational Analysis
3
2024
179
0.210
Why?
Head and Neck Neoplasms
2
2019
289
0.210
Why?
Kidney Neoplasms
2
2018
181
0.200
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
42
0.200
Why?
Chlamydia muridarum
1
2024
39
0.200
Why?
Homeodomain Proteins
1
2024
80
0.200
Why?
Lung Neoplasms
2
2019
643
0.200
Why?
Endometriosis
1
2023
15
0.200
Why?
Chlamydia Infections
1
2024
74
0.200
Why?
Gynecology
2
2020
52
0.200
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.190
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.190
Why?
CD4-Positive T-Lymphocytes
1
2024
165
0.190
Why?
Hepatocytes
2
2024
184
0.190
Why?
Fallopian Tube Neoplasms
2
2012
15
0.190
Why?
Immunotherapy
2
2021
251
0.190
Why?
Gestational Trophoblastic Disease
2
2012
2
0.180
Why?
CTLA-4 Antigen
1
2021
32
0.180
Why?
Genotype
2
2021
563
0.180
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.180
Why?
Estrogens
2
2023
228
0.180
Why?
Oncogene Fusion
1
2021
4
0.180
Why?
PTEN Phosphohydrolase
3
2020
55
0.180
Why?
Leiomyosarcoma
1
2021
22
0.170
Why?
Transcription Factors
3
2020
570
0.170
Why?
Diabetes, Gestational
1
2021
51
0.170
Why?
Cancer Vaccines
1
2021
78
0.170
Why?
Carcinosarcoma
2
2017
18
0.170
Why?
Infant, Small for Gestational Age
1
2020
36
0.160
Why?
Carcinoma, Papillary
1
2020
49
0.160
Why?
Neoplasms, Experimental
1
2020
111
0.160
Why?
Carcinoma, Transitional Cell
1
2020
54
0.160
Why?
Pregnancy in Diabetics
1
2020
25
0.160
Why?
Colonic Neoplasms
1
2021
163
0.160
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.160
Why?
Dermatology
1
2020
54
0.160
Why?
Radiotherapy
1
2020
128
0.160
Why?
Carcinoma, Lewis Lung
1
2019
10
0.160
Why?
Pregnancy Complications, Neoplastic
1
2019
21
0.160
Why?
Placenta Diseases
1
2019
13
0.160
Why?
Premature Birth
1
2021
150
0.160
Why?
Carcinoma, Renal Cell
2
2018
112
0.160
Why?
Skin Diseases
1
2020
118
0.160
Why?
Melanoma, Experimental
1
2019
34
0.150
Why?
Hodgkin Disease
1
2019
45
0.150
Why?
Odds Ratio
3
2015
563
0.150
Why?
Hepatic Veno-Occlusive Disease
1
2019
11
0.150
Why?
T-Lymphocytes
1
2021
318
0.150
Why?
DNA Polymerase II
1
2019
9
0.150
Why?
Fetal Diseases
1
2019
54
0.150
Why?
DNA Mismatch Repair
1
2019
18
0.150
Why?
Monocytes
1
2019
124
0.150
Why?
Sarcoma
1
2020
68
0.150
Why?
Pregnancy
7
2021
2642
0.150
Why?
Inflammation
2
2020
649
0.150
Why?
Urinary Bladder Neoplasms
1
2020
166
0.150
Why?
Methionine Adenosyltransferase
1
2018
19
0.150
Why?
CD8-Positive T-Lymphocytes
1
2019
140
0.150
Why?
Metformin
1
2020
82
0.140
Why?
Radiation Tolerance
1
2019
78
0.140
Why?
Logistic Models
3
2015
930
0.140
Why?
Nuclear Proteins
1
2020
247
0.140
Why?
Disease Models, Animal
6
2020
1483
0.140
Why?
DNA Helicases
1
2020
147
0.140
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.140
Why?
Programmed Cell Death 1 Receptor
1
2018
46
0.140
Why?
Rhabdomyosarcoma
1
2018
12
0.140
Why?
Intestinal Mucosa
2
2020
228
0.140
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
67
0.140
Why?
Tumor Necrosis Factor-alpha
2
2019
390
0.140
Why?
Pathology, Molecular
1
2017
27
0.140
Why?
Biopsy
5
2020
594
0.140
Why?
Hypoglycemic Agents
1
2020
223
0.140
Why?
Neoplastic Cells, Circulating
1
2017
34
0.130
Why?
Pregnancy Complications
1
2021
399
0.130
Why?
Osteosarcoma
1
2017
44
0.130
Why?
Acetaminophen
1
2019
272
0.130
Why?
DNA-Binding Proteins
2
2016
423
0.130
Why?
Vimentin
1
2016
31
0.130
Why?
Time Factors
3
2021
2987
0.130
Why?
Papillomaviridae
1
2017
102
0.120
Why?
Oligonucleotide Array Sequence Analysis
1
2017
412
0.120
Why?
Gene Expression Profiling
2
2019
1099
0.120
Why?
Cadherins
1
2016
61
0.120
Why?
Viral Load
1
2016
81
0.120
Why?
Flow Cytometry
1
2017
396
0.120
Why?
Skin Neoplasms
1
2020
496
0.120
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.110
Why?
Male
11
2024
26874
0.110
Why?
Neoplasms, Muscle Tissue
1
2015
12
0.110
Why?
Classification
1
2015
12
0.110
Why?
Colposcopy
1
2015
17
0.110
Why?
Malate Dehydrogenase
1
2014
8
0.110
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
17
0.110
Why?
Lipogenesis
1
2014
32
0.110
Why?
Mice, Inbred BALB C
3
2021
304
0.110
Why?
Cytosol
1
2014
82
0.110
Why?
World Health Organization
1
2015
58
0.110
Why?
Histones
1
2016
315
0.110
Why?
Neoplasm, Residual
1
2015
169
0.110
Why?
Mammary Neoplasms, Experimental
1
2015
122
0.110
Why?
Multiple Myeloma
1
2009
3013
0.110
Why?
Adolescent
4
2024
6713
0.110
Why?
Obesity
1
2022
1176
0.110
Why?
High-Throughput Nucleotide Sequencing
3
2021
178
0.110
Why?
Antineoplastic Agents
2
2021
1216
0.100
Why?
Gastrointestinal Tract
1
2014
110
0.100
Why?
Intestines
1
2014
159
0.100
Why?
Cell Line, Tumor
4
2020
1429
0.100
Why?
Oncogenes
1
2013
61
0.100
Why?
Patient Selection
1
2015
269
0.100
Why?
Clusterin
1
2012
8
0.100
Why?
Membrane Proteins
1
2015
344
0.100
Why?
Pancreatic Neoplasms
1
2015
208
0.100
Why?
Dose-Response Relationship, Drug
3
2024
1365
0.100
Why?
Histocytochemistry
1
2012
44
0.090
Why?
Risk Factors
3
2015
3971
0.090
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
24
0.090
Why?
Strongyloidiasis
1
2012
9
0.090
Why?
Follow-Up Studies
2
2016
2294
0.090
Why?
Treatment Outcome
3
2021
5508
0.090
Why?
Prednisone
1
2012
100
0.090
Why?
Cytomegalovirus Infections
1
2012
38
0.090
Why?
Vascular Endothelial Growth Factor A
1
2012
186
0.090
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.090
Why?
Teratoma
1
2011
23
0.090
Why?
Matrix Metalloproteinases
1
2011
47
0.090
Why?
Sensitivity and Specificity
3
2020
871
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Image Processing, Computer-Assisted
1
2012
234
0.090
Why?
Phenotype
3
2019
792
0.080
Why?
Tissue Array Analysis
3
2015
45
0.080
Why?
Glucocorticoids
1
2012
234
0.080
Why?
Tumor Cells, Cultured
2
2021
441
0.080
Why?
Epigenesis, Genetic
1
2012
396
0.080
Why?
Infant, Newborn
3
2021
2871
0.070
Why?
Pregnancy Outcome
2
2021
255
0.070
Why?
Pilot Projects
2
2023
725
0.070
Why?
Phosphatidylinositol 3-Kinases
2
2024
147
0.070
Why?
Telemedicine
1
2015
490
0.070
Why?
Necrosis
2
2024
169
0.070
Why?
Cell Differentiation
2
2024
667
0.070
Why?
Hysterectomy
2
2021
90
0.070
Why?
Cell Nucleus
2
2021
189
0.070
Why?
Host-Pathogen Interactions
2
2021
130
0.070
Why?
Societies, Medical
2
2019
200
0.070
Why?
Gene Expression Regulation
3
2023
1004
0.070
Why?
Neoplasms
1
2017
1314
0.070
Why?
Consensus
2
2020
195
0.060
Why?
Ventricular Pressure
1
2006
16
0.060
Why?
Isoproterenol
1
2006
56
0.060
Why?
Terminology as Topic
2
2018
69
0.060
Why?
Kaplan-Meier Estimate
2
2018
485
0.060
Why?
Serum Response Factor
1
2006
45
0.060
Why?
Combined Modality Therapy
2
2020
641
0.060
Why?
Kidney
1
2010
716
0.060
Why?
Practice Guidelines as Topic
2
2019
498
0.060
Why?
Neoplasm Metastasis
2
2018
235
0.060
Why?
Cytokines
2
2020
622
0.060
Why?
Cells, Cultured
2
2021
1583
0.060
Why?
Proportional Hazards Models
2
2017
446
0.060
Why?
Chromatography, Liquid
2
2016
245
0.050
Why?
Bilirubin
1
2024
43
0.050
Why?
Species Specificity
1
2024
194
0.050
Why?
Tandem Mass Spectrometry
2
2016
255
0.050
Why?
Heart
1
2006
352
0.050
Why?
Steroids
1
2024
61
0.050
Why?
Interleukin-10
1
2024
81
0.050
Why?
Th1 Cells
1
2024
51
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
853
0.050
Why?
Phylogeny
1
2024
229
0.050
Why?
Government Agencies
1
2022
15
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
67
0.050
Why?
Hemorrhage
1
2024
225
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
10
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.050
Why?
Parturition
1
2021
50
0.040
Why?
Phthalazines
1
2021
20
0.040
Why?
Remission Induction
1
2021
218
0.040
Why?
Quinazolines
1
2021
32
0.040
Why?
Lymphocyte Activation
1
2021
161
0.040
Why?
Vulva
1
2020
18
0.040
Why?
Taurine
1
2020
18
0.040
Why?
Research Report
1
2020
19
0.040
Why?
Metabolic Networks and Pathways
1
2021
89
0.040
Why?
Herb-Drug Interactions
1
2020
31
0.040
Why?
Mucin-2
1
2020
8
0.040
Why?
Toxicity Tests
1
2020
57
0.040
Why?
Alkaline Phosphatase
1
2020
92
0.040
Why?
Risk
1
2021
315
0.040
Why?
Piperazines
1
2021
125
0.040
Why?
Molecular Targeted Therapy
1
2021
135
0.040
Why?
Chemokines
1
2020
77
0.040
Why?
United States
3
2016
5215
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
580
0.040
Why?
Birth Weight
1
2020
127
0.040
Why?
Preoperative Period
1
2020
47
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
37
0.040
Why?
Pyrimidines
1
2021
199
0.040
Why?
Endothelium
1
2019
38
0.040
Why?
Mice, Transgenic
2
2014
566
0.040
Why?
Colon
1
2020
107
0.040
Why?
Chest Pain
1
2019
55
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
59
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
30
0.040
Why?
Receptors, Progesterone
1
2020
68
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
191
0.040
Why?
Glutamine
1
2020
177
0.040
Why?
Dyspnea
1
2019
78
0.040
Why?
Estrogen Receptor alpha
1
2020
86
0.040
Why?
Fatal Outcome
1
2019
193
0.040
Why?
Liver Function Tests
1
2019
48
0.040
Why?
Mice, Inbred Strains
1
2019
165
0.040
Why?
Drug Synergism
1
2019
147
0.040
Why?
Gestational Age
1
2020
415
0.040
Why?
Imaging, Three-Dimensional
1
2019
150
0.040
Why?
Mice, Nude
1
2019
230
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
218
0.040
Why?
Nephrectomy
1
2018
81
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
36
0.030
Why?
Lymph Node Excision
1
2019
133
0.030
Why?
Ultrasonography, Prenatal
1
2019
180
0.030
Why?
Mixed Tumor, Mullerian
1
2017
3
0.030
Why?
Cell Lineage
1
2018
92
0.030
Why?
Skin
1
2020
416
0.030
Why?
DNA Copy Number Variations
1
2018
116
0.030
Why?
Macrophages
1
2019
357
0.030
Why?
Lymph Nodes
1
2019
253
0.030
Why?
Anal Canal
1
2017
27
0.030
Why?
Disease-Free Survival
1
2017
461
0.030
Why?
Dietary Supplements
1
2020
470
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
38
0.030
Why?
Telomerase
1
2016
26
0.030
Why?
Child
2
2024
7194
0.030
Why?
Transcriptome
1
2019
357
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
51
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Signal Transduction
1
2023
1724
0.030
Why?
Diet
1
2020
591
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
81
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
122
0.030
Why?
S100 Proteins
1
2015
33
0.030
Why?
Cell Count
1
2015
143
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
68
0.030
Why?
Pressure
1
2015
100
0.030
Why?
Cell Hypoxia
1
2015
82
0.030
Why?
Drug Evaluation, Preclinical
1
2015
141
0.030
Why?
Blood Vessels
1
2015
73
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
51
0.030
Why?
Genetic Predisposition to Disease
1
2018
525
0.030
Why?
Random Allocation
1
2015
286
0.030
Why?
Prospective Studies
1
2020
2433
0.030
Why?
Immunoenzyme Techniques
1
2014
134
0.030
Why?
Radiotherapy Dosage
1
2015
256
0.030
Why?
Apoptosis
1
2020
1120
0.030
Why?
Proteome
1
2016
175
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
182
0.030
Why?
Likelihood Functions
1
2014
56
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
262
0.030
Why?
Multivariate Analysis
1
2015
601
0.030
Why?
Vaccination
1
2016
294
0.030
Why?
Genes, erbB-1
1
2013
9
0.030
Why?
Lipid Metabolism
1
2014
189
0.030
Why?
Anti-Bacterial Agents
1
2019
816
0.030
Why?
Gene Frequency
1
2013
97
0.030
Why?
Adiposity
1
2014
147
0.020
Why?
SEER Program
1
2013
105
0.020
Why?
Mesentery
1
2012
14
0.020
Why?
Communication
1
2015
255
0.020
Why?
Insulin Resistance
1
2014
281
0.020
Why?
Diet, High-Fat
1
2014
230
0.020
Why?
Neoplasms, Glandular and Epithelial
1
2012
41
0.020
Why?
Research Design
1
2015
368
0.020
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.020
Why?
Pregnancy Proteins
1
2012
5
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
7
0.020
Why?
Rural Health Services
1
2015
177
0.020
Why?
Ovary
1
2012
101
0.020
Why?
Angiopoietin-2
1
2012
14
0.020
Why?
Angiopoietin-1
1
2012
16
0.020
Why?
Socioeconomic Factors
1
2015
609
0.020
Why?
Ivermectin
1
2012
10
0.020
Why?
Antiparasitic Agents
1
2012
11
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
38
0.020
Why?
Infant
1
2020
3709
0.020
Why?
Hydatidiform Mole
1
2011
1
0.020
Why?
Algorithms
1
2015
673
0.020
Why?
RNA, Messenger
1
2014
1134
0.020
Why?
Interleukin-6
1
2012
271
0.020
Why?
Isoenzymes
1
2011
171
0.020
Why?
Crohn Disease
1
2012
115
0.020
Why?
Promoter Regions, Genetic
1
2012
465
0.020
Why?
Gene Expression
1
2012
618
0.020
Why?
Radiography
1
2011
469
0.020
Why?
Risk Assessment
1
2015
1349
0.020
Why?
Cell Line
1
2012
1020
0.020
Why?
Cohort Studies
1
2013
1576
0.020
Why?
DNA Methylation
1
2012
573
0.020
Why?
Rats
1
2014
3228
0.020
Why?
Blotting, Western
1
2006
587
0.010
Why?
Myocardium
1
2006
471
0.010
Why?
Age Factors
1
2006
1120
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description